Trainingwell supported · human data

Cardio first or weights first? For type 2 diabetes it barely matters

Across 27 randomised trials in 965 people with type 2 diabetes, combined aerobic and resistance training improved body fat, HbA1c, fasting glucose and blood lipids whether cardio or weights came first. Direct comparisons between the two orders were not significant, so neither sequence can be declared superior.

Compiled by FitTools from the study cited below

The citation, figures and study details on this page are taken mechanically from the source record. No human editor has reviewed it.

Added to Pulse 29 September 2026

Study design
Meta-analysis
Evidence
well supported
Published
29 September 2026

Key takeaway

What it shows: The case for combining cardio and weights is solid here, pooled from 27 trials in 965 people with type 2 diabetes; the ordering question is not. Head-to-head comparisons between the two sequences were uncertain and rated low certainty, so the rankings are hints rather than verdicts.

Study details

Design
Meta-analysis
Authors
Li Z, Liu C, Liu Y
Journal
Endocrine
Published
2026
Added to Pulse
29 September 2026

Why it matters

Exercise guidance for type 2 diabetes recommends combining aerobic work and resistance training, an approach known as concurrent training. What has never been settled is whether the order matters: cardio before weights, or weights before cardio. People with diabetes who train make this choice every session, and plausible arguments exist for both arrangements. This review pooled the randomised evidence to test whether sequence changes outcomes such as blood sugar control, body composition, blood lipids and blood pressure.

What they did

The authors ran a network meta-analysis, a technique that allows treatments to be compared even when few trials have tested them directly against each other. They searched five databases for randomised controlled trials published up to January 2026 and included 27 trials with 965 participants with type 2 diabetes. The trials delivered concurrent training with either aerobic work first or resistance work first, and outcomes covered body composition, HbA1c, fasting glucose, insulin resistance, blood lipids and blood pressure. The two sequences were then ranked using unadjusted probability estimates.

What they found

Both sequences beat control conditions on body fat percentage, HbA1c, fasting blood glucose, total cholesterol, triglycerides and LDL cholesterol. In the unadjusted rankings, resistance work first tended to rank highest for body composition, glycaemic control, insulin resistance and most lipid outcomes, while aerobic work first ranked highest for systolic and diastolic blood pressure. Crucially, the direct comparisons between the two orders were not significant, and the certainty of the evidence was rated low. Further analyses suggested training duration, participant sex and participant age may all sway which order looks better.

Where it fits

Combined aerobic and resistance training is already recommended for managing type 2 diabetes, and this analysis reinforces that both configurations deliver measurable cardiometabolic improvements. What it adds is a systematic look at sequencing, and the honest answer is that the data cannot crown a winner. The rankings hint that different orders might suit different goals, blood pressure versus blood sugar for instance, but the authors are explicit that these signals are exploratory. Trials designed specifically to test order head to head are the missing piece.

What it means for you

If you combine cardio and weights in the same session, this is reassurance that the combination itself is doing the work: both orders improved body fat, blood sugar and cholesterol in these trials. There is no solid basis here to reorganise your session, and the hints of difference between sequences were too uncertain to act on. Preference, energy levels and enjoyment are as good a tiebreaker as the current evidence offers.

The source

Effects of concurrent training sequence on cardiometabolic risk factors in patients with type 2 diabetes: a systematic review and network meta-analysis. Endocrine 2026

DOI: 10.1007/s12020-026-04775-5

Read the study →

Related tools & guides

More research, with the reality check: every study we hold → · this week’s → · or open the full Pulse feed →